Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/16/2010CN1894276B HCV NS3-NS4A protease resistance mutants
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1889949B PDK-1/Akt signaling inhibitors
06/16/2010CN1886141B T-type calcium channel inhibitor
06/16/2010CN1882598B Phosphinic acid derivatives
06/16/2010CN1879672B Effective components of glabrous sarcandra herb - total polyphenol, its preparation method and application
06/16/2010CN1872846B Method of preparing 2-benzothiazepines derivative
06/16/2010CN1871234B 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible NO-synthase
06/16/2010CN1871015B Immunemodulating oligosaccharides
06/16/2010CN1867566B Aminopyrones and their use as ATM inhibitors
06/16/2010CN1867341B Compositions for controlling parasites comprising a combination of abamectin and milbemycin
06/16/2010CN1867310B Composition and method for promoting hair growth
06/16/2010CN1864691B Use of compound scalarafuran
06/16/2010CN1863805B Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
06/16/2010CN1863557B In-situ gelling drug delivery system
06/16/2010CN1857281B Adefovir dipivoxil liposome injection and its preparing method
06/16/2010CN1857232B Biodegradable nano magnetic capsule loading medicine and its preparing process
06/16/2010CN1853622B Medicament use of setooquen
06/16/2010CN1839124B Succinate and malonate salt of trans-4-(1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
06/16/2010CN1839118B Methods and compositions for treating amyloid-related diseases
06/16/2010CN1837226B Separation of medical derivatives from phoenix-tail fern and use thereof
06/16/2010CN1837194B Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones compound
06/16/2010CN1830978B Pyrazolo [4,3-c]-quinolin-3-one compound, preparation method and use thereof
06/16/2010CN1829711B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing them
06/16/2010CN1824044B Application of a combination for preparing medicine and food dual purpose product for preventing and treating synchysis
06/16/2010CN1822822B Saquinavir mesylate oral dosage form
06/16/2010CN1809364B Compositions and methods for increasing telomerase activity
06/16/2010CN1805944B Cyclic hydroxylamine as psychoactive compounds
06/16/2010CN1805938B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
06/16/2010CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
06/16/2010CN1774428B M-stage kinesin inhibitor
06/16/2010CN1771040B Remedy for diabetes.
06/16/2010CN1771032B Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
06/16/2010CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives
06/16/2010CN1756533B Non-pegylated long-circulating liposomes
06/16/2010CN1731981B Liposome of glucocorticoids
06/16/2010CN1726026B Antioxidant for fats, oils and food
06/16/2010CN1694871B Imidazolopyridines and methods of making and using the same
06/16/2010CN1680258B Amorphous water-soluble calcium citrate salts and method of making and using same
06/16/2010CN1635864B Oligosaccharide aldonic acids and their topical use
06/16/2010CN1596103B Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
06/16/2010CN1543338B Chitin microparticles and their medical uses
06/16/2010CN1526409B Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process
06/16/2010CN1451041B Compound, composition and method for the treatment of inflammatory and inflammatory-related disorders
06/16/2010CN1393446B 稠合吡唑化合物 Fused pyrazole compounds
06/16/2010CN101743316A Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
06/16/2010CN101743246A 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents
06/16/2010CN101743244A Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
06/16/2010CN101743243A Compounds and compositions as ITPKB inhibitors
06/16/2010CN101743242A Heterocyclic compounds useful as RAF kinase inhibitors
06/16/2010CN101743240A ((phenyl)imidazolyl)methylheteroaryl compounds
06/16/2010CN101743239A cyanoisoquinoline
06/16/2010CN101743234A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
06/16/2010CN101743232A compounds and methods for modulating fxr
06/16/2010CN101743229A quinazolinamide derivatives
06/16/2010CN101743228A Process for preparing telmisartan
06/16/2010CN101743227A Novel histidine derivative
06/16/2010CN101743226A Inhibitors of 11beta-hydroxysteroid dehydrogenase
06/16/2010CN101743224A 7-substituted indole mcl-1 inhibitors
06/16/2010CN101743223A Novel compounds as cannabinoid receptor ligands
06/16/2010CN101743021A Stabilized suspension
06/16/2010CN101743012A Novel one step process for preparing cross-linked poly(allylamine) polymers
06/16/2010CN101743011A The use of (3-amino-2-fluoropropyl) phosphinic acid for treatment of nerd
06/16/2010CN101743010A Stable fat emulsion containing prostaglandin e1
06/16/2010CN101743009A Pharmaceutical compositions and methods of treating dry eye disorders
06/16/2010CN101743008A Antiviral drugs for treatment or prevention of dengue infection
06/16/2010CN101743007A Inhibitors of akt/pkb with anti-tumor activity
06/16/2010CN101743006A Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
06/16/2010CN101743005A Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine
06/16/2010CN101743004A Therapeutic compositions and the use thereof
06/16/2010CN101743003A Combination of CHK and PARP inhibitors for the treatment of cancers
06/16/2010CN101743002A New method for preparing isofagomine and its derivatives
06/16/2010CN101743001A Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
06/16/2010CN101743000A Animal pest control method
06/16/2010CN101742999A Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient
06/16/2010CN101742998A magnesium compositions and uses thereof
06/16/2010CN101742997A Transglutaminase inhibitor comprising chlorogenic acid and a method for producing thereof
06/16/2010CN101742996A Treatment of virally induced lesions
06/16/2010CN101742995A detecting succinylacetone
06/16/2010CN101742994A Telomerase activating compounds and methods of use thereof
06/16/2010CN101742993A Axomadol for treating pain from arthritis
06/16/2010CN101742991A Honokiol analogs and their use in treating cancers
06/16/2010CN101742989A Microspheres having core/shell structure
06/16/2010CN101742987A Process for obtaining steroidal phosphate compounds
06/16/2010CN101742986A Stable formulation of amorphous perindopril salts, a process for the preparation thereof on industrial scale and use thereof in the treatment of hypertension
06/16/2010CN101742985A An inhalable composition
06/16/2010CN101742926A Lipid composition for improving brain function
06/16/2010CN101742911A di-substituted amides for enhancing glutamatergic synaptic responses
06/16/2010CN101742910A Method of treating brain cancer
06/16/2010CN101742908A therapeutic pyrazoloquinoline derivatives
06/16/2010CN101742907A Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and spla2 inhibitor combination therapies
06/16/2010CN101742906A Tri-aryl compounds and compositions comprising the same
06/16/2010CN101738438A Detection method of related substances of nitrendipine and atenolol compound composition
06/16/2010CN101736406A Method for discovering active components of traditional Chinese medicine by metabolic forecast and virtual sieving
06/16/2010CN101736050A Preparation method of arctigenin
06/16/2010CN101736003A Japanese blood fluke miRNAs and applications thereof
06/16/2010CN101735410A Reduction-sensitive amphiphilic block copolymer and micelle thereof
06/16/2010CN101735336A Oligomeric fucosylated glycosaminoglycan and preparation method thereof
06/16/2010CN101735335A Water soluble cantharidin and/or norcantharidin chitosan derivative and preparation method thereof
06/16/2010CN101735329A Pholiota adiosapose polysaccharide and preparation method thereof
1 ... 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 ... 7860